• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Colgate-Palmolive Company Announces 2nd Quarter 2025 Results

    8/1/25 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $CL alert in real time by email

     

    Colgate-Palmolive Company (NYSE:CL):

    • Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales
    • GAAP EPS increased 2% to $0.91; Base Business EPS* increased 1% to $0.92
    • GAAP Gross profit margin decreased 50 basis points to 60.1%; Base Business Gross profit margin* decreased 70 basis points to 60.1%
    • Net cash provided by operations was $1,484 million for the first six months of 2025
    • The Company's leadership in toothpaste continued with its global market share at 41.1% year to date
    • The Company's leadership in manual toothbrushes continued with its global market share at 32.4% year to date
    • The Company updated its organic sales growth guidance for full year 2025

    Second Quarter Total Company Results (GAAP)

    ($ in millions except per share amounts)

    2025

    2024

    Change

    Net Sales

    $5,110

    $5,058

    +1.0%

    EPS (diluted)

    $0.91

    $0.89

    +2%

     

     

     

     

     

     

     

     

    Second Quarter Total Company Results (Base Business - Non-GAAP)*

     

    2025

    2024

    Change

    Organic Sales Growth

    +1.8%

    Base Business EPS (diluted)

    $0.92

    $0.91

    +1%

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 8 - Non-GAAP Reconciliations" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

    Colgate-Palmolive Company (NYSE:CL) today reported results for second quarter 2025. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business second quarter results, "I am pleased that Colgate-Palmolive people achieved another quarter of net sales, organic sales and earnings per share growth in the face of continued difficult market conditions worldwide, with organic sales growth improving sequentially versus the first quarter despite an even greater negative impact from lower private label pet sales.

    "We feel we are well positioned to deal with the year-to-date volatility in category growth and uncertainty in global markets. Guided by our strategic framework, including our focus on innovation and the strength of our global portfolio, our teams on the ground continue to execute with excellence and focus to achieve our 2025 financial targets."

    Separately, the Company today announced a new three-year productivity program to drive future growth and support the Company's 2030 strategy. The program includes initiatives to better align the Company's organizational structure to support its strategic initiatives, optimize the Company's global supply chain to drive agility and efficiencies and simplify and streamline its organizational structure to reduce overhead costs. The productivity program is projected to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300 million over the course of the three-year program. It is expected that substantially all charges resulting from the productivity program will be incurred by December 31, 2028.

    Full Year 2025 Guidance

    Based on current spot rates and including the estimated impact of tariffs announced and finalized as of July 31, 2025:

    • The Company still expects net sales to be up low single digits, now including a flat to low-single-digit negative impact from foreign exchange.
    • The Company now expects organic sales growth to be at the low end of 2% to 4%, including the impact over the course of 2025 of the planned exit from private label pet sales.
    • On a GAAP basis, the Company still expects both gross profit margin and advertising investment to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.
    • On a non-GAAP (Base Business) basis, the Company still expects both gross profit margin and advertising to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.

    Divisional Performance

    See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.

    Second Quarter Sales Growth By Division

    (% change 2Q 2025 vs. 2Q 2024 except % of Total Company Sales)

     

     

     

     

    % of Total

    Company

    Sales

    Net

    Sales

    Organic

    Sales*

    As

    Reported

    Volume**

    Organic

    Volume

    Pricing

    FX

    North America(1)

    20%

    -1.0%

    -0.9%

    -0.4%

    -0.4%

    -0.5%

    -0.1%

    Latin America

    24%

    -4.8%

    +3.4%

    +0.4%

    +0.4%

    +3.0%

    -8.2%

    Europe(1)

    14%

    +7.8%

    +2.0%

    -0.2%

    -0.2%

    +2.2%

    +5.7%

    Asia Pacific

    13%

    +0.8%

    —%

    -1.6%

    -1.6%

    +1.6%

    +0.9%

    Africa/Eurasia

    6%

    +8.0%

    +7.7%

    +4.3%

    +4.3%

    +3.4%

    +0.2%

    Hill's

    23%

    +3.8%

    +2.0%

    +0.1%

    -0.9%

    +2.9%

    +0.8%

     

     

     

     

     

     

     

     

    Total Company

    100%

    +1.0%

    +1.8%

    —%

    -0.2%

    +2.0%

    -1.0%

    Note: Table may not sum due to rounding.

     

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

     

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 6 - Geographic Sales Analysis Percentage Changes" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

     

    **The impact of the acquisition of the Prime100 pet food business on as reported volume was 1.0% and 0.2% for Hill's Pet Nutrition and Total Company, respectively.

    Second Quarter Operating Profit By Division

    ($ in millions)

     

     

    2Q 2025

    % Change vs

    2Q 2024

    % to Net

    Sales

    Change in basis

    points vs 2Q 2024

    % to Net Sales

    North America(1)

    $194

    -9%

    18.9%

    -170

    Latin America

    $367

    -12%

    30.4%

    -250

    Europe(1)

    $184

    9%

    25.0%

    +40

    Asia Pacific

    $187

    -4%

    27.2%

    -150

    Africa/Eurasia

    $65

    1%

    22.0%

    -140

    Hill's

    $264

    13%

    22.9%

    +180

     

     

     

     

     

    Total Company, As Reported

    $1,080

    -1%

    21.1%

    -50

    Total Company, Base Business*

    $1,089

    -3%

    21.3%

    -80

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

     

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 8 - Non-GAAP Reconciliations" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

    Prepared Materials and Webcast Information

    At approximately 7:00 a.m. ET today, the Company will post its prepared materials regarding second quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

    At 8:30 a.m. ET today, the Company will host a conference call regarding second quarter results. To access this call as a webcast, please go to Colgate-Palmolive's website at www.colgatepalmolive.com.

    About Colgate-Palmolive

    Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. The Company is recognized for its leadership and innovation in promoting sustainability and community wellbeing, including its achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children's oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991. For more information about Colgate-Palmolive's global business and how the Company is building a future to smile about, visit www.colgatepalmolive.com. CL-E

    Market Share Information

    Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

    Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

    Cautionary Statement on Forward-Looking Statements

    This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management's current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of tariffs, the impact of geopolitical conflicts and tensions, such as the war in Ukraine, the conflict in the Middle East, tensions between China and Taiwan and global trade relations, cost reduction plans (including the productivity program announced on August 1, 2025), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company's views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company's business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company's filings with the SEC (including, but not limited to, the information set forth under the captions "Risk Factors" and "Cautionary Statement on Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company's Investor Relations Department or on the Company's website at www.colgatepalmolive.com.

    Non-GAAP Financial Measures

    The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

    • Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges resulting from the ERISA litigation matter and the 2022 Global Productivity Initiative and acquisition-related costs.
    • Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
    • Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

    This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company's underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See "Geographic Sales Analysis Percentage Changes" for the three and six months ended June 30, 2025 versus 2024 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

    Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company's normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company's business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company's underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See "Non-GAAP Reconciliations" for the three and six months ended June 30, 2025 and 2024 included with this release for a reconciliation of these financial measures to the related GAAP measures.

    The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

    As management uses free cash flow before dividends to evaluate the Company's ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See "Condensed Consolidated Statements of Cash Flows" for the six months ended June 30, 2025 and 2024 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

    (See attached tables for second quarter results.)

     

     

     

     

    Table 1

    Colgate-Palmolive Company

     

    Condensed Consolidated Statements of Income

     

    For the Three Months Ended June 30, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

    2025

     

    2024

     

     

     

     

     

    Net sales

     

    $

    5,110

     

     

    $

    5,058

     

     

     

     

     

     

    Cost of sales

     

     

    2,041

     

     

     

    1,992

     

     

     

     

     

     

    Gross profit

     

     

    3,069

     

     

     

    3,066

     

     

     

     

     

     

    Gross profit margin

     

     

    60.1

    %

     

     

    60.6

    %

     

     

     

     

     

    Selling, general and administrative expenses

     

     

    1,963

     

     

     

    1,939

     

     

     

     

     

     

    Other (income) expense, net

     

     

    26

     

     

     

    35

     

     

     

     

     

     

    Operating profit

     

     

    1,080

     

     

     

    1,092

     

     

     

     

     

     

    Operating profit margin

     

     

    21.1

    %

     

     

    21.6

    %

     

     

     

     

     

    Non-service related postretirement costs

     

     

    23

     

     

     

    22

     

     

     

     

     

     

    Interest expense

     

     

    71

     

     

     

    78

     

     

     

     

     

     

    Interest income

     

     

    21

     

     

     

    18

     

     

     

     

     

     

    Income before income taxes

     

     

    1,007

     

     

     

    1,010

     

     

     

     

     

     

    Provision for income taxes

     

     

    234

     

     

     

    243

     

     

     

     

     

     

    Effective tax rate

     

     

    23.2

    %

     

     

    24.1

    %

     

     

     

     

     

    Net income including noncontrolling interests

     

     

    773

     

     

     

    767

     

     

     

     

     

     

    Less: Net income attributable to noncontrolling interests

     

     

    30

     

     

     

    36

     

     

     

     

     

     

    Net income attributable to Colgate-Palmolive Company

     

    $

    743

     

     

    $

    731

     

     

     

     

     

     

    Earnings per common share

     

     

     

     

    Basic

     

    $

    0.92

     

     

    $

    0.89

     

    Diluted

     

    $

    0.91

     

     

    $

    0.89

     

     

     

     

     

     

    Supplemental Income Statement Information

     

     

     

     

    Average common shares outstanding

     

     

     

     

    Basic

     

     

    810.2

     

     

     

    819.7

     

    Diluted

     

     

    813.3

     

     

     

    823.7

     

     

     

     

     

     

    Advertising

     

    $

    678

     

     

    $

    706

     

     

     

     

     

    Table 2

    Colgate-Palmolive Company

     

    Condensed Consolidated Statements of Income

     

    For the Six Months Ended June 30, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

    2025

     

    2024

     

     

     

     

     

    Net sales

     

    $

    10,021

     

     

    $

    10,124

     

     

     

     

     

     

    Cost of sales

     

     

    3,965

     

     

     

    4,019

     

     

     

     

     

     

    Gross profit

     

     

    6,056

     

     

     

    6,105

     

     

     

     

     

     

    Gross profit margin

     

     

    60.4

    %

     

     

    60.3

    %

     

     

     

     

     

    Selling, general and administrative expenses

     

     

    3,861

     

     

     

    3,855

     

     

     

     

     

     

    Other (income) expense, net

     

     

    39

     

     

     

    111

     

     

     

     

     

     

    Operating profit

     

     

    2,156

     

     

     

    2,139

     

     

     

     

     

     

    Operating profit margin

     

     

    21.5

    %

     

     

    21.1

    %

     

     

     

     

     

    Non-service related postretirement costs

     

     

    95

     

     

     

    44

     

     

     

     

     

     

    Interest expense

     

     

    137

     

     

     

    151

     

     

     

     

     

     

    Interest income

     

     

    35

     

     

     

    33

     

     

     

     

     

     

    Income before income taxes

     

     

    1,959

     

     

     

    1,977

     

     

     

     

     

     

    Provision for income taxes

     

     

    460

     

     

     

    482

     

     

     

     

     

     

    Effective tax rate

     

     

    23.5

    %

     

     

    24.4

    %

     

     

     

     

     

    Net income including noncontrolling interests

     

     

    1,499

     

     

     

    1,495

     

     

     

     

     

     

    Less: Net income attributable to noncontrolling interests

     

     

    66

     

     

     

    81

     

     

     

     

     

     

    Net income attributable to Colgate-Palmolive Company

     

    $

    1,433

     

     

    $

    1,414

     

     

     

     

     

     

    Earnings per common share

     

     

     

     

    Basic(1)

     

    $

    1.77

     

     

    $

    1.72

     

    Diluted(1)

     

    $

    1.76

     

     

    $

    1.71

     

     

     

     

     

     

    Supplemental Income Statement Information

     

     

     

     

    Average common shares outstanding

     

     

     

     

    Basic

     

     

    811.2

     

     

     

    821.3

     

    Diluted

     

     

    814.2

     

     

     

    824.9

     

     

     

     

     

     

    Advertising

     

    $

    1,346

     

     

    $

    1,378

     

    Note:

    (1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.

     

     

     

     

     

     

    Table 3

    Colgate-Palmolive Company

     

    Condensed Consolidated Balance Sheets

     

    As of June 30, 2025, December 31, 2024 and June 30, 2024

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

     

     

     

     

    June 30,

     

    December 31,

     

    June 30,

     

     

    2025

     

    2024

     

    2024

    Cash and cash equivalents

     

    $

    1,215

     

     

    $

    1,096

     

     

    $

    1,110

     

    Receivables, net

     

     

    1,773

     

     

     

    1,521

     

     

     

    1,825

     

    Inventories

     

     

    2,120

     

     

     

    1,987

     

     

     

    1,922

     

    Other current assets

     

     

    888

     

     

     

    713

     

     

     

    789

     

    Property, plant and equipment, net

     

     

    4,529

     

     

     

    4,422

     

     

     

    4,392

     

    Goodwill

     

     

    3,696

     

     

     

    3,272

     

     

     

    3,320

     

    Other intangible assets, net

     

     

    1,904

     

     

     

    1,756

     

     

     

    1,814

     

    Other assets

     

     

    1,345

     

     

     

    1,279

     

     

     

    1,308

     

    Total assets

     

    $

    17,470

     

     

    $

    16,046

     

     

    $

    16,480

     

     

     

     

     

     

     

     

    Total debt

     

    $

    8,758

     

     

    $

    7,949

     

     

    $

    8,676

     

    Other current liabilities

     

     

    5,161

     

     

     

    5,099

     

     

     

    4,820

     

    Other non-current liabilities

     

     

    2,499

     

     

     

    2,454

     

     

     

    2,502

     

    Total liabilities

     

     

    16,418

     

     

     

    15,502

     

     

     

    15,998

     

    Total Colgate-Palmolive Company shareholders' equity

     

     

    702

     

     

     

    212

     

     

     

    123

     

    Noncontrolling interests

     

     

    350

     

     

     

    332

     

     

     

    359

     

    Total liabilities and equity

     

    $

    17,470

     

     

    $

    16,046

     

     

    $

    16,480

     

     

     

     

     

     

     

     

    Supplemental Balance Sheet Information

     

     

     

     

     

     

    Debt less cash, cash equivalents and marketable securities(1)

     

    $

    7,346

     

     

    $

    6,693

     

     

    $

    7,341

     

    Working capital % of sales

     

     

    (2.9

    )%

     

     

    (5.2

    )%

     

     

    (2.5

    )%

    Note:

    (1) Marketable securities of $197, $160 and $225 as of June 30, 2025, December 31, 2024 and June 30, 2024, respectively, are included in Other current assets.

     

     

     

     

    Table 4

    Colgate-Palmolive Company

     

    Condensed Consolidated Statements of Cash Flows

     

    For the Six Months Ended June 30, 2025 and 2024

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

     

     

    2025

     

    2024

    Operating Activities

     

     

     

     

    Net income including noncontrolling interests

     

    $

    1,499

     

     

    $

    1,495

     

    Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:

     

     

    Depreciation and amortization

     

     

    299

     

     

     

    307

     

    ERISA litigation matter

     

     

    65

     

     

     

    —

     

    Restructuring and termination benefits, net of cash

     

     

    (13

    )

     

     

    48

     

    Stock-based compensation expense

     

     

    55

     

     

     

    43

     

    Deferred income taxes

     

     

    (17

    )

     

     

    (92

    )

    Cash effects of changes in:

     

     

     

     

    Receivables

     

     

    (152

    )

     

     

    (309

    )

    Inventories

     

     

    3

     

     

     

    (17

    )

    Accounts payable and other accruals

     

     

    (248

    )

     

     

    194

     

    Other non-current assets and liabilities

     

     

    (7

    )

     

     

    2

     

    Net cash provided by (used in) operations

     

     

    1,484

     

     

     

    1,671

     

     

     

     

     

     

    Investing Activities

     

     

     

     

    Capital expenditures

     

     

    (232

    )

     

     

    (243

    )

    Purchases of marketable securities and investments

     

     

    (384

    )

     

     

    (243

    )

    Proceeds from sale of marketable securities and investments

     

     

    350

     

     

     

    178

     

    Payment for acquisition, net of cash acquired

     

     

    (293

    )

     

     

    —

     

    Other investing activities

     

     

    (1

    )

     

     

    4

     

    Net cash provided by (used in) investing activities

     

     

    (560

    )

     

     

    (304

    )

     

     

     

     

     

    Financing Activities

     

     

     

     

    Short-term borrowing (repayment) less than 90 days, net

     

     

    (30

    )

     

     

    736

     

    Principal payments on debt

     

     

    (139

    )

     

     

    (500

    )

    Proceeds from issuance of debt

     

     

    497

     

     

     

    2

     

    Dividends paid

     

     

    (880

    )

     

     

    (867

    )

    Purchases of treasury shares

     

     

    (516

    )

     

     

    (989

    )

    Proceeds from exercise of stock options

     

     

    65

     

     

     

    455

     

    Other financing activities

     

     

    136

     

     

     

    (43

    )

    Net cash provided by (used in) financing activities

     

     

    (867

    )

     

     

    (1,206

    )

     

     

     

     

     

    Effect of exchange rate changes on Cash and cash equivalents

     

     

    62

     

     

     

    (17

    )

    Net increase (decrease) in Cash and cash equivalents

     

     

    119

     

     

     

    144

     

    Cash and cash equivalents at beginning of the period

     

     

    1,096

     

     

     

    966

     

    Cash and cash equivalents at end of the period

     

    $

    1,215

     

     

    $

    1,110

     

     

     

     

     

     

    Supplemental Cash Flow Information

     

     

     

     

    Free cash flow before dividends (Net cash provided by operations less Capital expenditures)

     

     

     

     

    Net cash provided by operations

     

    $

    1,484

     

     

    $

    1,671

     

    Less: Capital expenditures

     

     

    (232

    )

     

     

    (243

    )

    Free cash flow before dividends

     

    $

    1,252

     

     

    $

    1,428

     

     

     

     

     

     

     

     

     

     

     

    Income taxes paid

     

    $

    530

     

     

    $

    505

     

    Interest paid

     

    $

    137

     

     

    $

    161

     

     

     

     

     

     

     

     

     

    Table 5

    Colgate-Palmolive Company

     

     

     

     

     

    Segment Information

     

     

     

     

     

    For the Three and Six Months Ended June 30, 2025 and 2024

     

     

     

     

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

    2025

     

    2024

     

    2025

     

    2024

    Net Sales

     

     

     

     

     

     

     

     

    Oral, Personal and Home Care

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    North America(1)

     

    $

    1,027

     

     

    $

    1,037

     

     

    $

    2,025

     

     

    $

    2,073

     

    Latin America

     

     

    1,207

     

     

     

    1,267

     

     

     

    2,350

     

     

     

    2,520

     

    Europe(1)

     

     

    738

     

     

     

    685

     

     

     

    1,427

     

     

     

    1,358

     

    Asia Pacific

     

     

    687

     

     

     

    682

     

     

     

    1,378

     

     

     

    1,408

     

    Africa/Eurasia

     

     

    295

     

     

     

    273

     

     

     

    566

     

     

     

    549

     

     

     

     

     

     

     

     

     

     

    Total Oral, Personal and Home Care

     

     

    3,954

     

     

     

    3,944

     

     

     

    7,746

     

     

     

    7,908

     

     

     

     

     

     

     

     

     

     

    Pet Nutrition

     

     

    1,157

     

     

     

    1,114

     

     

     

    2,275

     

     

     

    2,216

     

     

     

     

     

     

     

     

     

     

    Total Net Sales

     

    $

    5,110

     

     

    $

    5,058

     

     

    $

    10,021

     

     

    $

    10,124

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

    2025

     

    2024

     

    2025

     

    2024

    Operating Profit

     

     

     

     

     

     

     

     

    Oral, Personal and Home Care

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    North America(1)

     

    $

    194

     

     

    $

    213

     

     

    $

    390

     

     

    $

    427

     

    Latin America

     

     

    367

     

     

     

    417

     

     

     

    715

     

     

     

    822

     

    Europe(1)

     

     

    184

     

     

     

    169

     

     

     

    356

     

     

     

    321

     

    Asia Pacific

     

     

    187

     

     

     

    195

     

     

     

    385

     

     

     

    402

     

    Africa/Eurasia

     

     

    65

     

     

     

    64

     

     

     

    122

     

     

     

    130

     

     

     

     

     

     

     

     

     

     

    Total Oral, Personal and Home Care

     

     

    997

     

     

     

    1,058

     

     

     

    1,968

     

     

     

    2,102

     

     

     

     

     

     

     

     

     

     

    Pet Nutrition

     

     

    264

     

     

     

    235

     

     

     

    523

     

     

     

    433

     

    Corporate(2)

     

     

    (181

    )

     

     

    (201

    )

     

     

    (334

    )

     

     

    (397

    )

     

     

     

     

     

     

     

     

     

    Total Operating Profit

     

    $

    1,080

     

     

    $

    1,092

     

     

    $

    2,156

     

     

    $

    2,139

     

    Note: Table may not sum due to rounding.

     

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

     

    (2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.

     

    Corporate Operating profit (loss) for the three months ended June 30, 2025 included acquisition-related costs of $9.

     

    Corporate Operating profit (loss) for the six months ended June 30, 2025 included charges resulting from the ERISA litigation matter of $15 and acquisition-related costs of $9.

     

    Corporate Operating profit (loss) for the three months ended June 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $27.

     

    Corporate Operating profit (loss) for the six months ended June 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $63.

    Table 6

    Colgate-Palmolive Company

     

    Geographic Sales Analysis Percentage Changes

     

    For the Three Months Ended June 30, 2025 vs. 2024

     

    (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    COMPONENTS OF SALES CHANGE

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Pricing

     

     

     

     

     

     

     

     

     

     

     

     

    Coupons

     

     

     

     

    Sales

     

     

     

     

     

     

     

    Consumer &

     

     

     

     

    Change

     

    Organic

     

    As Reported

     

    Organic

     

    Trade

     

    Foreign

    Region

     

    As Reported

     

    Sales Change

     

    Volume(1)

     

    Volume

     

    Incentives

     

    Exchange

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total Company

     

    1.0

    %

     

    1.8

    %

     

    —

    %

     

    (0.2

    )%

     

    2.0

    %

     

    (1.0

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    North America(2)

     

    (1.0

    )%

     

    (0.9

    )%

     

    (0.4

    )%

     

    (0.4

    )%

     

    (0.5

    )%

     

    (0.1

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Latin America

     

    (4.8

    )%

     

    3.4

    %

     

    0.4

    %

     

    0.4

    %

     

    3.0

    %

     

    (8.2

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Europe(2)

     

    7.8

    %

     

    2.0

    %

     

    (0.2

    )%

     

    (0.2

    )%

     

    2.2

    %

     

    5.7

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Asia Pacific

     

    0.8

    %

     

    —

    %

     

    (1.6

    )%

     

    (1.6

    )%

     

    1.6

    %

     

    0.9

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Africa/Eurasia

     

    8.0

    %

     

    7.7

    %

     

    4.3

    %

     

    4.3

    %

     

    3.4

    %

     

    0.2

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total CP Products

     

    0.2

    %

     

    1.7

    %

     

    —

    %

     

    —

    %

     

    1.7

    %

     

    (1.5

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Hill's

     

    3.8

    %

     

    2.0

    %

     

    0.1

    %

     

    (0.9

    )%

     

    2.9

    %

     

    0.8

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Emerging Markets(3)

     

    (1.1

    )%

     

    2.8

    %

     

    0.2

    %

     

    0.2

    %

     

    2.6

    %

     

    (3.9

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Developed Markets

     

    2.8

    %

     

    0.9

    %

     

    (0.1

    )%

     

    (0.5

    )%

     

    1.4

    %

     

    1.4

    %

    Note: Table may not sum due to rounding.

     

    (1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.2%, 1.0% and 0.4% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively.

     

    (2) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

     

    (3) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

    Table 7

    Colgate-Palmolive Company

     

    Geographic Sales Analysis Percentage Changes

     

    For the Six Months Ended June 30, 2025 vs. 2024

     

    (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    COMPONENTS OF SALES CHANGE

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Pricing

     

     

     

     

     

     

     

     

     

     

     

     

    Coupons

     

     

     

     

    Sales

     

     

     

     

     

     

     

    Consumer &

     

     

     

     

    Change

     

    Organic

     

    As Reported

     

    Organic

     

    Trade

     

    Foreign

    Region

     

    As Reported

     

    Sales Change

     

    Volume(1)

     

    Volume

     

    Incentives

     

    Exchange

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total Company

     

    (1.0

    )%

     

    1.6

    %

     

    —

    %

     

    (0.1

    )%

     

    1.7

    %

     

    (2.7

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    North America(2)

     

    (2.3

    )%

     

    (2.0

    )%

     

    (1.4

    )%

     

    (1.4

    )%

     

    (0.6

    )%

     

    (0.3

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Latin America

     

    (6.8

    )%

     

    3.7

    %

     

    1.6

    %

     

    1.6

    %

     

    2.1

    %

     

    (10.4

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Europe(2)

     

    5.2

    %

     

    3.7

    %

     

    1.4

    %

     

    1.4

    %

     

    2.3

    %

     

    1.5

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Asia Pacific

     

    (2.2

    )%

     

    (1.6

    )%

     

    (2.6

    )%

     

    (2.6

    )%

     

    1.0

    %

     

    (0.6

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Africa/Eurasia

     

    3.2

    %

     

    4.8

    %

     

    1.0

    %

     

    1.0

    %

     

    3.7

    %

     

    (1.6

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total CP Products

     

    (2.0

    )%

     

    1.3

    %

     

    —

    %

     

    —

    %

     

    1.3

    %

     

    (3.4

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Hill's

     

    2.6

    %

     

    2.5

    %

     

    (0.1

    )%

     

    (0.6

    )%

     

    3.0

    %

     

    (0.3

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Emerging Markets(3)

     

    (3.7

    )%

     

    2.2

    %

     

    0.2

    %

     

    0.2

    %

     

    2.0

    %

     

    (5.9

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Developed Markets

     

    1.2

    %

     

    1.0

    %

     

    (0.2

    )%

     

    (0.4

    )%

     

    1.5

    %

     

    —

    %

    Note: Table may not sum due to rounding.

     

    (1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.1%, 0.5% and 0.2% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively.

     

    (2) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

     

    (3) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

    Table 8

    Colgate-Palmolive Company

     

    Non-GAAP Reconciliations

     

    For the Three Months Ended June 30, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

     

     

     

     

    Gross Profit

     

    2025

     

    2024

     

     

    Gross profit, GAAP

    $

    3,069

     

     

    $

    3,066

     

     

     

    2022 Global Productivity Initiative

     

    —

     

     

     

    9

     

     

     

    Gross profit, non-GAAP

    $

    3,069

     

     

    $

    3,075

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basis Point

    Gross Profit Margin

    2025

     

    2024

     

    Change

    Gross profit margin, GAAP

     

    60.1

    %

     

     

    60.6

    %

     

    (50

    )

    2022 Global Productivity Initiative

     

    —

    %

     

     

    0.2

    %

     

     

    Gross profit margin, non-GAAP

     

    60.1

    %

     

     

    60.8

    %

     

    (70

    )

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, General and Administrative Expenses

    2025

     

    2024

     

     

    Selling, general and administrative expenses, GAAP

    $

    1,963

     

     

    $

    1,939

     

     

     

    2022 Global Productivity Initiative

     

     

    —

     

     

     

    (2

    )

     

     

    Selling, general and administrative expenses, non-GAAP

    $

    1,963

     

     

    $

    1,937

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Other (Income) Expense, Net

    2025

     

    2024

     

     

    Other (income) expense, net, GAAP

    $

    26

     

     

    $

    35

     

     

     

    Acquisition-related costs

     

     

    (9

    )

     

     

    —

     

     

     

    2022 Global Productivity Initiative

     

     

    —

     

     

     

    (16

    )

     

     

    Other (income) expense, net, non-GAAP

    $

    17

     

     

    $

    20

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Profit

     

    2025

     

    2024

     

    % Change

    Operating profit, GAAP

    $

    1,080

     

     

    $

    1,092

     

     

    (1

    )%

    Acquisition-related costs

     

     

    9

     

     

     

    —

     

     

     

    2022 Global Productivity Initiative

     

     

    —

     

     

     

    27

     

     

     

    Operating profit, non-GAAP

    $

    1,089

     

     

    $

    1,118

     

     

    (3

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basis Point

    Operating Profit Margin

    2025

     

    2024

     

    Change

    Operating profit margin, GAAP

     

    21.1

    %

     

     

    21.6

    %

     

    (50

    )

    Acquisition-related costs

     

     

    0.2

    %

     

     

    —

    %

     

     

    2022 Global Productivity Initiative

     

     

    —

    %

     

     

    0.5

    %

     

     

    Operating profit margin, non-GAAP

     

    21.3

    %

     

     

    22.1

    %

     

    (80

    )

    Note: Tables may not sum due to rounding. The impact of non-GAAP adjustments may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.

    Table 8

    Continued

    Colgate-Palmolive Company

     

    Non-GAAP Reconciliations

     

    For the Three Months Ended June 30, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    2025

     

    Income

    Before

    Income

    Taxes

     

    Provision

    For Income

    Taxes(1)

     

    Net Income

    Including

    Noncontrolling

    Interests

     

    Less: Income

    Attributable to

    Noncontrolling

    Interests

     

    Net Income

    Attributable

    To

    Colgate-

    Palmolive

    Company

     

    Effective

    Income

    Tax Rate(2)

     

    Diluted

    Earnings

    Per Share

    As Reported GAAP

    $

    1,007

     

    $

    234

     

    $

    773

     

    $

    30

     

    $

    743

     

    23.2

    %

     

    $

    0.91

    Acquisition-related costs

     

    9

     

     

    2

     

     

    7

     

     

    —

     

     

    7

     

    —

    %

     

     

    0.01

    Non-GAAP

    $

    1,016

     

    $

    236

     

    $

    780

     

    $

    30

     

    $

    750

     

    23.2

    %

     

    $

    0.92

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    2024

     

    Income

    Before

    Income

    Taxes

     

    Provision

    For Income

    Taxes(1)

     

    Net Income

    Including

    Noncontrolling

    Interests

     

    Less: Income

    Attributable to

    Noncontrolling

    Interests

     

    Net Income

    Attributable

    To

    Colgate-

    Palmolive

    Company

     

    Effective

    Income

    Tax Rate(2)

     

    Diluted

    Earnings

    Per Share

    As Reported GAAP

    $

    1,010

     

    $

    243

     

    $

    767

     

    $

    36

     

    $

    731

     

    24.1

    %

     

    $

    0.89

    2022 Global Productivity Initiative

     

    27

     

     

    4

     

     

    23

     

     

    —

     

     

    23

     

    (0.3

    )%

     

     

    0.02

    Non-GAAP

    $

    1,036

     

    $

    247

     

    $

    789

     

    $

    36

     

    $

    753

     

    23.8

    %

     

    $

    0.91

    Note: Tables may not sum due to rounding. The impact of non-GAAP adjustments may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.

     

    (1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

     

    (2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

    Table 9

    Colgate-Palmolive Company

     

    Non-GAAP Reconciliations

     

    For the Six Months Ended June 30, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

     

     

     

     

    Gross Profit

     

    2025

     

    2024

     

     

    Gross profit, GAAP

     $

    6,056

     

     

    $

    6,105

     

     

     

    2022 Global Productivity Initiative

     

    —

     

     

     

    9

     

     

     

    Gross profit, non-GAAP

    $

    6,056

     

     

    $

    6,114

     

     

     

     

     

     

     

     

     

     

    Gross Profit Margin

    2025

     

    2024

     

    Change

    Gross profit margin, GAAP

     

    60.4

    %

     

     

    60.3

    %

     

    10

     

    2022 Global Productivity Initiative

     

    —

    %

     

     

    0.1

    %

     

     

    Gross profit margin, non-GAAP

     

    60.4

    %

     

     

    60.4

    %

     

    —

     

     

     

     

     

     

     

    Selling, General and Administrative Expenses

    2025

     

    2024

     

     

    Selling, general and administrative expenses, GAAP

    $

    3,861

     

     

    $

    3,855

     

     

     

    ERISA litigation matter

     

     

    (15

    )

     

     

    —

     

     

     

    2022 Global Productivity Initiative

     

    —

     

     

     

    (3

    )

     

     

    Selling, general and administrative expenses, non-GAAP

    $

    3,845

     

     

    $

    3,852

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basis Point

    Selling, General and Administrative Expenses as a Percentage of Net Sales

    2025

     

    2024

     

    Change

    Selling, general and administrative expenses as a percentage of Net sales, GAAP

     

    38.5

    %

     

     

    38.1

    %

     

    40

     

    ERISA litigation matter

     

     

    (0.1

    )%

     

     

    —

    %

     

     

    2022 Global Productivity Initiative

     

    —

    %

     

     

    (0.1

    )%

     

     

    Selling, general and administrative expenses as a percentage of Net sales, non-GAAP

     

    38.4

    %

     

     

    38.0

    %

     

    40

     

     

     

     

     

     

     

    Other (Income) Expense, Net

    2025

     

    2024

     

     

    Other (income) expense, net, GAAP

    $

    39

     

     

    $

    111

     

     

     

    Acquisition-related costs

     

     

    (9

    )

     

     

    —

     

     

     

    2022 Global Productivity Initiative

     

    —

     

     

     

    (51

    )

     

     

    Other (income) expense, net, non-GAAP

    $

    30

     

     

    $

    60

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Profit

     

    2025

     

    2024

     

    % Change

    Operating profit, GAAP

    $

    2,156

     

     

    $

    2,139

     

     

    1

    %

    ERISA litigation matter

     

     

    15

     

     

     

    —

     

     

     

    Acquisition-related costs

     

     

    9

     

     

     

    —

     

     

     

    2022 Global Productivity Initiative

     

    —

     

     

     

    63

     

     

     

    Operating profit, non-GAAP

    $

    2,181

     

     

    $

    2,202

     

     

    (1

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basis Point

    Operating Profit Margin

    2025

     

    2024

     

    Change

    Operating profit margin, GAAP

     

    21.5

    %

     

     

    21.1

    %

     

    40

     

    ERISA litigation matter

     

    0.2

    %

     

     

    —

    %

     

     

    Acquisition-related costs

     

     

    0.1

    %

     

     

    —

    %

     

     

    2022 Global Productivity Initiative

     

    —

    %

     

     

    0.7

    %

     

     

    Operating profit margin, non-GAAP

     

    21.8

    %

     

     

    21.8

    %

     

    —

     

     

    Non-Service Related Postretirement Costs

    2025

     

    2024

     

     

    Non-service related postretirement costs, GAAP

    $

    95

     

     

    $

    44

     

     

     

    ERISA litigation matter

     

     

    (50

    )

     

     

    —

     

     

     

    Non-service related postretirement costs, non-GAAP

    $

    45

     

     

    $

    44

     

     

     

    Note: Tables may not sum due to rounding. The impact of non-GAAP adjustments may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.

    Table 9

    Continued

    Colgate-Palmolive Company

     

    Non-GAAP Reconciliations

     

    For the Six Months Ended June 30, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    2025

     

    Income

    Before

    Income Taxes

     

    Provision

    For

    Income

    Taxes(1)

     

    Net Income

    Including

    Noncontrolling

    Interests

     

    Less: Income

    Attributable to

    Noncontrolling

    Interests

     

    Net Income

    Attributable

    To

    Colgate-

    Palmolive

    Company

     

    Effective

    Income

    Tax Rate(2)

     

    Diluted

    Earnings

    Per Share

    As Reported GAAP

    $

    1,959

     

    $

    460

     

    $

    1,499

     

    $

    66

     

    $

    1,433

     

    23.5

    %

     

    $

    1.76

    ERISA litigation matter

     

    65

     

     

    12

     

     

    53

     

     

    —

     

     

    53

     

    (0.1

    )%

     

     

    0.06

    Acquisition-related costs

     

    9

     

     

    2

     

     

    7

     

     

    —

     

     

    7

     

    —

    %

     

     

    0.01

    Non-GAAP

    $

    2,034

     

    $

    475

     

    $

    1,559

     

    $

    66

     

    $

    1,493

     

    23.4

    %

     

    $

    1.83

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    2024

     

    Income

    Before

    Income Taxes

     

    Provision

    For

    Income

    Taxes(1)

     

    Net Income

    Including

    Noncontrolling

    Interests

     

    Less: Income

    Attributable to

    Noncontrolling

    Interests

     

    Net Income

    Attributable

    To

    Colgate-

    Palmolive

    Company

     

    Effective

    Income

    Tax Rate(2)

     

    Diluted

    Earnings

    Per Share

    As Reported GAAP

    $

    1,977

     

    $

    482

     

    $

    1,495

     

    $

    81

     

    $

    1,414

     

    24.4

    %

     

    $

    1.71

    2022 Global Productivity Initiative

     

    63

     

     

    10

     

     

    53

     

     

    —

     

     

    53

     

    (0.3

    )%

     

     

    0.07

    Non-GAAP

    $

    2,040

     

    $

    492

     

    $

    1,548

     

    $

    81

     

    $

    1,467

     

    24.1

    %

     

    $

    1.78

    Note: Tables may not sum due to rounding. The impact of non-GAAP adjustments may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.

     

    (1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

     

    (2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustments on Income before income taxes and Provision for income taxes.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250801612356/en/

    Investor Relations: [email protected]

    Communications: [email protected]

    Get the next $CL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CL

    DatePrice TargetRatingAnalyst
    10/28/2024$105.00 → $101.00Buy → Hold
    Stifel
    9/24/2024$121.00Overweight
    Piper Sandler
    9/16/2024$100.00Equal Weight → Underweight
    Wells Fargo
    9/9/2024$107.00 → $109.00Buy → Hold
    Deutsche Bank
    7/26/2024Buy → Hold
    HSBC Securities
    7/24/2024$103.00 → $95.00Buy → Hold
    Jefferies
    7/23/2024$110.00Buy
    TD Cowen
    6/24/2024$109.00Outperform
    Exane BNP Paribas
    More analyst ratings

    $CL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Colgate-Palmolive Company Announces 2nd Quarter 2025 Results

      Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales GAAP EPS increased 2% to $0.91; Base Business EPS* increased 1% to $0.92 GAAP Gross profit margin decreased 50 basis points to 60.1%; Base Business Gross profit margin* decreased 70 basis points to 60.1% Net cash provided by operations was $1,484 million for the first six months of 2025 The Company's leadership in toothpaste continued with its global market share at 41.1% year to date The Company's leadership in manual toothbrushes continued with its global market share at 32.4% year to date The Company upd

    8/1/25 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Webcasts 2025 Second Quarter Earnings Conference Call August 1, 2025 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 second quarter earnings conference call on Friday, August 1, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-presentations. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * C

    7/21/25 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate Declares Regular Quarterly Dividend

    The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on August 15, 2025, to shareholders of record on July 18, 2025. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed St

    6/12/25 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Colgate-Palmolive downgraded by Stifel with a new price target

    Stifel downgraded Colgate-Palmolive from Buy to Hold and set a new price target of $101.00 from $105.00 previously

    10/28/24 7:38:39 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Piper Sandler initiated coverage on Colgate-Palmolive with a new price target

    Piper Sandler initiated coverage of Colgate-Palmolive with a rating of Overweight and set a new price target of $121.00

    9/24/24 7:35:59 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Colgate-Palmolive from Equal Weight to Underweight and set a new price target of $100.00

    9/16/24 7:25:35 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    SEC Filings

    View All

    SEC Form 10-Q filed by Colgate-Palmolive Company

    10-Q - COLGATE PALMOLIVE CO (0000021665) (Filer)

    8/1/25 8:32:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits

    8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

    8/1/25 8:00:52 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 11-K filed by Colgate-Palmolive Company

    11-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

    6/25/25 4:13:13 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Norrington Lorrie M was granted 292 shares, increasing direct ownership by 0.76% to 38,513 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    7/2/25 4:14:02 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Newman Brian was granted 208 shares, increasing direct ownership by 5% to 4,830 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    7/2/25 4:14:01 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Bilbrey John P was granted 264 shares, increasing direct ownership by 0.74% to 36,156 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    7/2/25 4:12:54 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Financials

    Live finance-specific insights

    View All

    Colgate-Palmolive Company Announces 2nd Quarter 2025 Results

      Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales GAAP EPS increased 2% to $0.91; Base Business EPS* increased 1% to $0.92 GAAP Gross profit margin decreased 50 basis points to 60.1%; Base Business Gross profit margin* decreased 70 basis points to 60.1% Net cash provided by operations was $1,484 million for the first six months of 2025 The Company's leadership in toothpaste continued with its global market share at 41.1% year to date The Company's leadership in manual toothbrushes continued with its global market share at 32.4% year to date The Company upd

    8/1/25 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Webcasts 2025 Second Quarter Earnings Conference Call August 1, 2025 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 second quarter earnings conference call on Friday, August 1, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-presentations. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * C

    7/21/25 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate Declares Regular Quarterly Dividend

    The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on August 15, 2025, to shareholders of record on July 18, 2025. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed St

    6/12/25 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/13/24 5:02:36 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/9/23 11:15:26 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/9/22 3:43:30 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Leadership Updates

    Live Leadership Updates

    View All

    Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

    The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi

    2/10/25 6:30:00 AM ET
    $CL
    $HSIC
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical Specialities
    Health Care

    ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth

    IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.

    3/12/24 1:08:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company Appoints Lorrie Norrington as Lead Independent Director of the Board

    Colgate-Palmolive Company (NYSE:CL) today announced that its Board of Directors has appointed Lorrie Norrington as Lead Independent Director, effective March 1, 2023. Ms. Norrington will succeed Stephen I. Sadove, the Company's current Lead Independent Director. Mr. Sadove will remain on the Audit and Personnel and Organization Committees of the Colgate Board of Directors. Ms. Norrington joined the Company's Board in September 2015 and currently serves as Chair of the Nominating, Governance and Corporate Responsibility Committee. She brings extensive global corporate leadership, digital, e-commerce and ESG experience to this role, including her experience in several senior management roles

    1/3/23 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary